首页> 外国专利> Selective modulator of GPR55 receptor activity: Chromenopyrazole derivatives

Selective modulator of GPR55 receptor activity: Chromenopyrazole derivatives

机译:GPR55受体活性的选择性调节剂:铬吡唑衍生物

摘要

The present invention relates to a family of compounds derived from chromenopyrazoles having the formula (I) having the ability to modulate the receptors of the family of GPR55 cannabinoids and accordingly the invention relates to the family of compounds derived from chromenopyrazoles of formula , Neuropathic pain, osteoporosis and other diseases in which the GRP55 receptor has a physiological role, such as cancers such as bile duct cell carcinoma, breast cancer, ovarian cancer and prostate cancer, glioblastoma and skin cancer For the manufacture of a medicament. Selection drawing None
机译:本发明涉及衍生自具有式(I)的色诺吡唑的化合物的家族,其具有调节GPR55大麻素家族的受体的能力,因此,本发明涉及衍生自下式的色诺吡唑的化合物的家族:神经性疼痛,骨质疏松症和其中GRP55受体具有生理作用的其他疾病,例如胆管细胞癌,乳腺癌,卵巢癌和前列腺癌等癌症,胶质母细胞瘤和皮肤癌,用于制造药物。选型图无

著录项

  • 公开/公告号JP2018515499A5

    专利类型

  • 公开/公告日2019-06-06

    原文格式PDF

  • 申请/专利权人

    申请/专利号JP2017557942

  • 发明设计人

    申请日0000-00-00

  • 分类号C07D491/052;A61K31/496;A61P43;A61P3/10;A61P25/16;A61P25/28;A61P25/04;A61P19/10;A61P35;

  • 国家 JP

  • 入库时间 2022-08-21 12:25:07

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号